Fig. 2From: Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented eldersAssociations between CSF α-synuclein and longitudinal neuroimaging change in ADNI. Data from linear mixed-effects models (left) and cox proportional hazards models (right) were adjusted for age, gender, educational level and APOE ε4 genotype. Hippocampal volume on the y axis was log-transformed to ensure normality. Time (years) on the x axis indicated follow-up years, in which “0” indicating the baseline. All participants were classified into High and Low groups according to their baseline CSF α-synuclein concentration (High: greater than median; Low: less than median)Back to article page